Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices
NHS hospitals in England used £29,668,088 of indicative cost of Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is down 3.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Leeds Teaching Hpls Nhs Trust | £1,111,647 |
| Western Sussex Hospitals Nhs Found Trust | £1,029,247 |
| Oxford University Hospitals Nhs Ft | £943,031 |
| University Hpls Of Leicester Nhs Trust | £900,305 |
| Guy's & St Thomas' Nhs Foundation Trust | £745,422 |
| Royal Free London Nhs Foundation Trust | £699,643 |
| Medway Nhs Foundation Trust | £693,540 |
| University Hospitals Plymouth Nhs Trust | £637,843 |
| Barts Health Nhs Trust | £634,791 |
| Aintree University Hospital Nhs Ft | £594,354 |
The primary-care picture
Golimumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Golimumab medicine page.